Genetically Weakened Malaria Vaccine Protected 13 of 15 Volunteers Against a Mismatched Strain in Early Seattle Trial
An experimental genetically weakened malaria vaccine protected 13 of 15 volunteers in a small Seattle challenge trial, including against a parasite strain different from the one used to develop it.
Medical Daily ·